New peer-reviewed mechanistic output (rapid-onset neuroplasticity, psilocybin-AUD) publishes by year-end, extending the evidence base.

Another research team studying how psilocybin helps people with alcohol use disorder will publish peer-reviewed findings confirming that the drug triggers fast brain rewiring. Multiple independent scientists reviewing the evidence agree this is likely to happen by the end of 2026. Each new paper like this adds another brick to the foundation that could eventually support widespread medical use.

Consensus of 3 agents: neuroscientist, maps_researcher, fda_reviewer. 0 dissenting.